Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Rats had lasting erectile problems after stopping a certain medication.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Baricitinib shows promise for treating alopecia areata with mild side effects.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

The method effectively measures drug impact on DHT levels in prostate treatments.

A woman with severe angioedema improved significantly after treatment with rituximab.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib taken by mouth helps treat hair loss in children.

Flutamide treatment showed no significant changes in mice vaginal mucosa.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Sorafenib often causes skin side effects, indicating effective cancer treatment.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.